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Abstract  
G protein-coupled receptor kinase 2 (GRK2) is an important serine/threonine-kinase regulating 
different membrane receptors and intracellular proteins. Attenuation of Drosophila Gprk2 in 
embryos or adult flies induced a defective differentiation of somatic muscles, loss of fibers, and 
a flightless phenotype. In vertebrates, GRK2 hemizygous mice contained less but more 
hypertrophied skeletal muscle fibers than wild-type littermates. In C2C12 myoblasts 
overexpression of a GRK2 kinase-deficient mutant (K220R) caused precocious differentiation 
of cells into immature myotubes, which were wider in size and contained more fused nuclei, 
while GRK2 overexpression blunted differentiation. Moreover, p38MAPK and Akt pathways 
were activated at an earlier stage and to a greater extent in K220R-expressing cells or upon 
kinase downregulation, while the activation of both kinases was impaired in GRK2-
overexpressing cells. The impaired differentiation and fewer fusion events promoted by 
enhanced GRK2 levels were recapitulated by a p38MAPK mutant, which was able to mimic the 
inhibitory phosphorylation of p38MAPK by GRK2, whereas the blunted differentiation 
observed in GRK2-expressing clones was rescued in the presence of a constitutively active 
upstream stimulator of the p38MAPK pathway. These results suggest that balanced GRK2 
function is necessary for a timely and complete myogenic process. 
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Introduction 
Skeletal muscle mass is maintained by signaling pathways that control cell proliferation, 
differentiation, protein synthesis and degradation. Loss of muscle mass occurs in multiple 
settings including cancer, AIDS, cachexia, and neuromuscular disorders, as well as during 
aging, and is an important factor contributing to morbidity (Glass, 2010b). On the other hand, 
skeletal muscle hypertrophy, the increase in muscle mass that occurs as a result of an increase in 
load, is characterized by increased fiber size and protein synthesis (Serrano et al., 2008). 
Understanding the molecular pathways that regulate gain or loss of muscle mass is therefore 
crucial for treating muscle wasting-associated disorders. In Drosophila melanogaster, fusion 
between two different types of cells leads to the formation of a muscle precursor cell/myotube, 
which further fusion events transform into a multinucleated myotube. In vertebrates, skeletal 
myogenesis is initiated by the generation of myoblasts followed by their differentiation to 
myocytes and the formation of myofibers (Buckingham et al., 2003). In the mouse (Mus 
musculus), differentiated myoblasts elongate and migrate towards other myoblasts thus giving 
rise to a nascent and, later, to a mature myotube through fusion events among equivalent cells 
(Simionescu and Pavlath, 2011). In all cases, the determination of myoblasts and their 
differentiation are controlled by muscle regulatory factors that are activated at specific stages 
during myogenesis (Abmayr and Pavlath, 2012). 
In vertebrates, at least two important signalling pathways are strictly required for the success of 
this multistep complex program of myogenesis: those of phosphatidylinositol 3-kinase (PI3-K) 
and p38 mitogen activated protein kinase (p38MAPK), which regulate the activation of key 
muscle transcription factors as MyoD. PI3-Ks are important mediators of tyrosine kinase 
receptor signal transduction. Their inhibition blocks myogenesis (Glass, 2010a) as so happens 
with Akt, an important downstream target of PI3-K  (Fujio et al., 1999; Jiang et al., 1999; 
Conejo and Lorenzo, 2001). p38MAPK is also a central player in this process (Conejo et al., 
2002; Perdiguero et al., 2007a) acting through several well described mechanisms (Lluis et al., 
2006). p38MAPK are a family of Ser/Thr kinases, including p38αMAPK, p38βMAPK, 
p38γMAPK and p38δMAPK, that regulate important cellular processes such as stress responses, 
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differentiation and cell cycle control (Nebreda and Porras, 2000; Zarubin and Han, 2005). 
p38αMAPK is the isoform involved in the induction of myogenesis (De Alvaro et al., 2008) 
and, consistently, treatment with p38α/βMAPK inhibitors or experimental depletion of the 
p38MAPKα isoform prevent the fusion of immortalized myoblasts into myotubes, and also the 
induction of specific muscle differentiation genes (Cuenda and Cohen, 1999; Zetser et al., 1999; 
Li et al., 2000; Perdiguero et al., 2007a, b; Alonso-Chamorro et al., 2011), thus demonstrating 
the requirement of p38MAPKα/β during myogenesis (de Angelis et al., 2005; Keren et al., 
2005). The p38MAPK pathway seems also to be involved in the modulation of skeletal muscle 
differentiation by cell-to-cell contact and adhesion (Krauss, 2010) or mechanical stimulation 
(Niu et al., 2013) and in the epigenetic control of muscle regeneration (Palacios et al., 2010). In 
marked contrast to the PI3-K/Akt pathway, little is known about the upstream modulators of the 
p38MAPK pathway in myogenesis other than MAPK kinase (MAPKKs) (Nebreda and Porras, 
2000). Accordingly, it has been reported that forced activation of p38MAPK by ectopic 
expression of a constitutively active mutant of MKK6 is sufficient to override the inhibitory 
factors present in proliferating cells and to induce both the expression of differentiation markers 
and the appearance of multinucleated myotubes, reinforcing the idea that p38MAPK activity 
plays an essential role in muscle differentiation (Li et al., 2000; Wu et al., 2000; Perdiguero et 
al., 2007a). However, the mechanisms that regulate p38MAPK activity during muscle cell 
differentiation remain unidentified, although they appear to be different from those involved in 
the response to stress or cytokines.  
G protein-coupled receptor kinase 2 (GRK2) is a ubiquitous, essential protein kinase that is 
emerging as an integrative node in many signalling networks. Moreover, changes in GRK2 
abundance and activity have been identified in several inflammatory, cardiovascular disease, 
and tumor contexts, suggesting that those alterations may contribute to the initiation or 
development of certain pathologies (Penela et al., 2003; Salcedo et al., 2006; Garcia-Guerra et 
al., 2010). GRKs were initially identified as key players in the desensitization and 
internalization of multiple GPCRs, but GRK2 also phosphorylates several non-GPCR substrates 
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and dynamically associates with a variety of proteins related to signal transduction (Peregrin et 
al., 2006; Ribas et al., 2007; Penela et al., 2010) including, among others, certain p38MAPK 
isoforms (Peregrin et al., 2006). However the implication of GRK2 in the mechanisms 
controlling the regulation of skeletal muscle development and function as well as how this 
regulation could affect the functionality of this tissue remain to be investigated. In this study, we 
report the importance of GRK2 in the regulation of skeletal muscle myogenesis and elucidate 
possible downstream effectors.  
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Results 
Grpk2 is required for myogenesis in Drosophila melanogaster 
Drosophila is a model system that had been successfully used to analyze the effects of Grpk2, a 
GRK ortholog in the fly, on signaling of Smoothened (Molnar et al., 2007) and recapitulates the 
complex myogenesis process of vertebrates in a simpler manner. We reduced Grpk2 activity by 
injecting Gprk2 dsRNA into Dmef2Gal4>UAS-GPF embryos, and directly observed the muscle 
pattern under a fluorescence microscope. Injection of Gprk2 dsRNA caused aberrant 
morphology and late detachment of many muscles, what worsened with time (Figure 1A-D). 
This phenotype indicates a defective differentiation of somatic muscles under attenuation 
conditions for Grpk2, suggesting a role for this protein in myogenesis.  
Due to strong maternal contribution for Grpk2 and its early requirement during oogenesis, the 
study of its function during embryonic myogenesis is not possible, so an in depth analysis was 
performed during Drosophila adult myogenesis. We focused on the development of a subset of 
the indirect flight muscles (IFMs), the dorsal longitudinal muscles (DLMs) that consist in six 
muscles per hemithorax (Fernandes et al., 1991). We first attenuated Gprk2 function using the 
1151Gal4 line to drive the expression of an RNAi silencing construct, the UAS-Ri-Gprk2, at 
29ºC in all adult muscle precursors and found a significant increase in the number of flies with a 
flightless phenotype (31%) compared with controls (9%) (Figure 1E). However, the over-
expression with the same driver of the full-length protein had low effect in the flying ability of 
the adults (Figure 1E). When we made use of a combination of the Gal4/UAS and the Flp-
mediated recombination systems for generating stronger loss-of-function conditions (see 
Materials and Methods, and (Duffy, 2002)) the penetrance of the flightless phenotype 
drastically increased to 100%. This phenotype was associated with a reduction in the number of 
DLMs already visible at 48h after puparium formation (APF) (Figure 1F-I), suggestive of a 
failure in the splitting of the DLM larval templates (Roy and VijayRaghavan, 1998). We also 
observed motor defects in a test for climbing ability in these flies: 3 day-old flies deprived of 
Gprk2 function in adult muscles, showed a reduction in climbing speed compared to their 
control siblings (Supplementary Movies S1-2), demonstrating that in the absence of Gprk2 the 
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development of DLM muscles is compromised. However, due to the late expression of the 
1151Gal4 driver in adult muscle tendons (Soler et al., 2004), we could not discard a 
contribution of Gprk2 tendon-requirement to the late phenotype. To investigate whether there is 
a late requirement of Gprk2 function in DLM muscles we attenuated Gprk2 in differentiating 
DLM muscles using the IFM-specific UH3Gal4 driver (Katzemich et al., 2012). Besides an 
absence of any apparent defect in DLM splitting UH3Gal4>UAS-Ri-Gprk2 flies were flightless 
(100%, Figure 1E), indicating a late requirement of Gprk2 for muscle differentiation.  
 
GRK2 hemizygous mice present less skeletal muscle fibers and increased fiber size 
To investigate whether GRK2 could play similar functions in vertebrates, we analyzed hindlimb 
muscles (gastrocnemius) from wildtype (Wt) and GRK2+/- mice. These haploinsufficient mice 
constitute a good model to recapitulate differences in GRK2 expression of the same range to 
those observed during pathological conditions (Ribas et al., 2007; Penela et al., 2010) as well as 
to evaluate the potential of therapeutic strategies aimed at globally decreasing GRK2 
functionality in vivo. Downregulation of GRK2 expression levels in skeletal muscle of 
hemizygous mice were confirmed by immunoblot (Figure 2A) and also by qPCR (Figure 2B) 
and correlates with a decrease in kinase activity that can be detected in muscle lysates (data not 
shown).  
We observed no differences in muscle weight (Figure 2C) between Wt and GRK2+/- mice at 3 
months of age in the absence of significant differences in either food or water intake 
(Supplementary Figure S1). Morphological analysis of muscle sections revealed a decreased 
number of fibers with wider cross sections in GRK2+/- mice at both 3 and 9 months of age 
(Figure 2D-F). This decrease in fiber number in GRK2+/- animals was not apparent in newborn 
mice (Figure 2G-I) although they already showed a larger fiber size (Figure 2H), suggesting that 
fiber loss was taking place after birth and before 3 months of age while fiber growth is an earlier 
phenotype. These results suggest that GRK2 plays an important role in regulating myofiber 
growth and integrity also in vertebrates. 
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GRK2 overexpression impairs muscle differentiation in C2C12 myoblasts while a kinase-
deficient mutant accelerates this process, giving rise to immature myotubes 
We analyzed the expression of GRK2 protein during C2C12 myoblast differentiation, a well-
established in vitro model for this process (Liu et al., 2002; de Alvaro et al., 2005; De Alvaro et 
al., 2008). A moderate but significant decrease in GRK2 can be observed along C2C12 
differentiation (which correlates with a decrease in kinase activity as quantified in cell lysates, 
data not shown) suggesting that GRK2 expression is regulated during this process (Figure 3A). 
To investigate the contribution of GRK2 to myogenic differentiation, we generated several 
stable C2C12 cell lines that moderately overexpress (circa 2-fold increase) two different GRK2 
constructs: pcDNA3-GRK2-Wt (pc-GRK2) and pcDNA3- GRK2-K220R (pc-K220R) with a 
point mutation that impairs the kinase activity of GRK2 and inhibits events dependent on GRK2 
kinase activity but not those due to scaffolding abilities (Figure 3B and Supplementary Figure 
S2).  
C2C12 cells proliferate in culture as undifferentiated cells in high serum; upon confluence and 
serum withdrawal (differentiation medium), myoblasts differentiate into myocytes, which 
subsequently fuse into multinucleated myotubes (Buckingham, 2001; Jansen and Pavlath, 
2008). As expected, differentiated C2C12 myoblasts display a multinucleated tubular 
morphology, which was similarly observed in control cells after 4 days in culture (Figure 3C 
and Supplementary Figure S2). Interestingly, pc-K220R myoblasts fully differentiated to an 
extent that appeared similar to that of pcDNA3 cells. We observed multinucleated myotubes in 
pc-K220R myoblasts whereas pc-GRK2 myocytes were primarily mononuclear, exhibiting a 
severe defect in their ability to form multinucleated cells, even after four or more days in low 
serum (Figure 3C and Supplementary Figure S2). 
Differentiation of skeletal muscle cells involves the sequential expression of specific 
transcription factors such as MyoD, and also early and terminal differentiation markers such as 
myogenin and myosin heavy chain (MHC), respectively (Weintraub, 1993). As expected, 
pcDNA3 myotubes showed a temporal expression pattern of differentiation markers similar to 
that reported for C2C12 cells (De Alvaro et al., 2008). Interestingly, the elevation of MyoD and 
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myogenin levels started one day earlier in pc-K220R-expressing clones than in pcDNA3 
myotubes (Figure 3D and Supplementary Figure S2) and remained significantly higher than in 
control cells all along the process even when terminal differentiation was achieved. On the 
contrary, late differentiation markers such as Caveolin-3 and MHC, indicative of mature 
myotubes, were expressed at lower levels in pc-K220R myotubes along the process (Figure 3D 
and data not shown) and Caveolin-3 remained below control levels even at day four. On the 
other hand, pc-GRK2 cells did not express any of these skeletal muscle differentiation markers 
after four or more days in low serum (Figure 3D and Supplementary Figure S2). This cannot be 
ascribed to increased cell death occurring in GRK-overexpressing clones (Supplementary Figure 
S3 and data not shown). These results clearly demonstrate that enhanced GRK2 expression 
abrogates differentiation, whereas interfering with GRK2 function triggers an untimely 
differentiation process with increased early differentiation markers and a decreased expression 
of proteins characteristic of fully mature myotubes.  
 
GRK2 regulates the formation of membrane protrusions in myocytes 
Formation of membrane protrusions caused by polymerization of cortical actin at the plasma 
membrane is a first step towards myoblast fusion into multinucleated myotubes (Stoker and 
Gherardi, 1991). At the beginning of the differentiation process, low serum induced the 
formation of membrane ruffles in pc-K220R and pcDNA3 myoblasts (Figure 4A and B), which 
resulted in an enhanced percentage of cells with fused nuclei (Figure 4A and C). pc-K220R 
myotubes presented higher number of nuclei and a wider diameter than pcDNA3 myotubes 
(Figure 4D and E). In contrast, pc-GRK2 myoblasts failed to form membrane protrusions and 
fusion was impaired (Figure 4A-C). These data suggest that GRK2 kinase activity negatively 
regulates the fusion process of myoblasts into myotubes and that this could be due at least in 
part to the inability to form membrane protrusions. On the other hand, interfering with GRK2 
kinase activity generates membrane protrusions that are able to promote more fusion events per 
myotube. 
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Myoblast differentiation requires growth arrest and cycle cell exit, and thus we analyzed the 
expression of several cell cycle regulators such as p21 (Shen et al., 2003); retinoblastoma (Rb), 
(Poznic, 2009); and proliferating cell nuclear antigen (PCNA) (Shen et al., 2003; Essers et al., 
2005). We detected Rb in the hyperphosphorylated state and PCNA protein in proliferating 
myoblasts of the transfectant cells. Four days of differentiation in low serum produced 
sequential growth arrest with up-regulation of the expression of p21, reduction of Rb 
phosphorylation and down-regulation of PCNA (Supplementary Figure S4). The percentage of 
G0/G1 cells after four days in low serum was significantly increased to the same extent in all 
three transfectants, thus indicating that all cells exited the cell cycle in a similar manner 
(Supplementary Figure S4). Thus, GRK2 does not play a role in the growth arrest associated to 
skeletal muscle differentiation.  
 
GRK2 kinase activity regulates the Akt, p38MAPK and ERK routes during myogenic 
differentiation 
Differentiation of pcDNA3 myotubes occurs with enhanced phosphorylation of Akt and 
decreased phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 in C2C12 cells 
(Figure 5A), in agreement with our previous observations (Conejo and Lorenzo, 2001; de 
Alvaro et al., 2005; De Alvaro et al., 2008). Interestingly, we detected a moderately increased 
Akt phosphorylation on Ser473 in pc-K220R myoblasts at the earliest steps of the process 
(already visible at days 1 and 2), indicating that Akt is prematurely activated in these cells 
(Figure 5A). Furthermore, ERK1/2 remained phosphorylated after 2 days in low serum, but this 
phosphorylation declined more abruptly from day 3 in pc-K220R cells (Figure 5A). 
Phosphorylation of Akt was hardly detectable in undifferentiated pc-GRK2- myoblasts, whereas 
a decreased phosphorylation of ERK1/2 after day two was also observed in these cells (Figure 
5A).  
We also observed a clear phosphorylation on the activation loop residues Thr180/Tyr182 of 
p38MAPK, an important pathway required for muscle differentiation (Lluis et al., 2006; 
Perdiguero et al., 2007a), after day two in pc-DNA3 myotubes, whereas this phosphorylation 
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was blunted in pc-GRK2 cells (Figure 5B). This activation of p38MAPK during the 
differentiation process was accelerated in pc-K220R cells (Figure 5B). Thus, upon interference 
with GRK2 kinase activity, there is a prompt and sustained activation of p38MAPK that 
probably helps establish the precocious but immature differentiation program detected in pc-
K220R cells (see Discussion). 
In line with these results, silencing of GRK2 by adenovirus-driven expression of an sh-construct 
specific for this kinase (Lafarga et al., 2012) led to a differentiation dynamics most reminiscent 
to that observed in K220R-expressing cells (Supplementary Figure S5), including the 
upregulated phosphorylation profile of both p38MAPK and Akt proteins (Figure 5C). These 
data indicate that the phenotypic changes detected when GRK2 levels vary depend mostly on its 
kinase activity and are related to an altered p38MAPK activation status. Also, Western blot 
analysis of GRK2-expressing cells (Figure 5B and Supplementary Figure S6A) showed a 
decreased amount of phospho-p38MAPK (Thr180/Tyr182) in pc-GRK2, whereas phospho-
p38MAPK (Thr123), an inhibitory residue target for GRK2 located at the docking groove of the 
protein (Peregrin et al., 2006), was enhanced. In contrast, in pc-K220R cells we observed that 
the increase in phospho-p38MAPK (Thr180/Tyr182) paralleled a decrease in the phospho-
p38MAPK (Thr123) signal of endogenous p38MAPK. These results may explain how lowering 
GRK2 activity enhances p38MAPK activation and myogenesis, were consistent with what has 
been already described during the adipocyte differentiation process (Peregrin et al., 2006), and 
suggest a possible role for Thr123-p38 phosphorylation in downregulating p38MAPK activation 
in myogenesis.  
 
Modulation of the p38MAPK pathway correlates with the inhibitory effect of GRK2 on 
myogenesis 
To understand whether phosphorylation of p38MAPK by GRK2 is involved in the effect of the 
latter on myogenesis, C2C12 myoblasts were transiently transfected with Flag-p38αT123D, a 
p38MAPK mutant that mimics phosphorylation by GRK2, and with Flag-p38αWT as a control 
(Supplementary Figure S6B). Then cells were induced to differentiate in low serum and fusion 
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parameters were studied. There were no significant phenotypic differences between Flag-
p38αWT and C2C12 cultures in any of the parameters analyzed. In contrast, myotube formation 
process in Flag-p38αT123D cells was disrupted (Figure 6A and B). Accordingly, we observed 
that these cells failed to form membrane protrusions at the beginning of the differentiation 
process (Figure 6B and C) and this observation was accompanied by a low number of cells with 
fused nuclei (25% and 10% respectively) (Figure 6D). Consequently, the few myoblasts that 
fused into myotubes contained lower number of nuclei (Figure 6E) and displayed a shorter 
diameter (Figure 6F) than control cells.  
Interestingly, when differentiation-incompetent GRK2-overexpressing cells were infected with 
a constitutively active mutant of the MKK6 protein (termed MKK6-E), a potent and direct 
activator of p38MAPK, a reversion of the GRK2-induced phenotype was detected, and cells 
started to differentiate in a manner more reminiscent of controls (Figure 6G), and the expression 
of key myogenic markers such as MHC (almost undetectable in control GRK2-cells 4 days after 
differentiation) was rescued along with stimulatory p38-phosphorylation in MKK6-E-infected 
GRK2-expressing cells (Figure 6H and Supplementary Figure S6C). These results demonstrate 
that overexpression of GRK2 negatively regulates the activation of signalling cascades 
implicated in skeletal muscle differentiation and that this inhibition can be overcome by 
activation of the p38MAPK pathway.  
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Discussion  
Skeletal myogenesis is a highly orchestrated multistep process that involves the determination 
of multipotential mesoderm cells to give rise to myoblasts. Exit of myoblasts from the cell cycle 
is followed by an increase in the expression of myogenic transcription factors and formation of 
multinucleated myotubes and by the expression of myofibrillar proteins (Buckingham et al., 
2003; Jansen and Pavlath, 2008). A timely regulation of skeletal muscle formation is essential 
for normal development. Its dysregulation is the basis for certain pathological conditions such 
as muscular dystrophies and inflammatory myopathies in which prominent muscle loss and 
degeneration take place (Glass, 2010b). In the present study, we characterize the mechanisms 
underlying the effects of GRK2 on muscle differentiation, and reveal the important role of this 
kinase in the regulation of the kinetics of the myogenic process.  
Drosophila melanogaster constitutes one of the key model systems to study myogenesis since it 
recapitulates the process observed in vertebrates but simplified to one precursor cell giving rise 
to one myotube and one adult fiber. Using this model to target Gprk2, a Drosophila ortholog of 
vertebrate GRKs (Molnar et al., 2007), we have detected both in Drosophila embryos and in 
newborn flies severe muscular dysfunction accompanied by fiber loss upon Gprk2 silencing or 
depletion. Gprk2 silencing in adult flies impaired motor activities such as climbing and flight 
behavior, and this phenotype further deteriorated with age. A reduction in the number of DLMs 
present in Gprk2-silenced or depleted flies, which was more evident with age, demonstrated an 
essential role for Gprk2 both on the differentiation and on the stability of muscles in this system. 
Importantly, GRK2 hemizygous mice show a significantly reduced fiber number in muscles 
both at 3 and at 9 months of age accompanied by an increased fiber size. This skeletal muscle 
hypertrophy can be regarded as a compensatory response of the tissue to try to counteract the 
decreased fiber number, or, instead, as a phenomenon triggered by GRK2 downregulation in 
parallel to fiber loss. This second hypothesis seems to better fit the results observed in 
vertebrates, where the same amount of fibers that are, however, already larger in size are 
detected in newborn mice. The contribution to the observed muscle phenotype of other cell 
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types that also present lower levels of GRK2 in hemizygous mice cannot be ruled out. However, 
the hypertrophic phenotype seems not to be specific for skeletal muscle, since we also detect a 
hypertrophy of cardiomyocytes of GRK2+/- mice with aging (unpublished data) with no 
differences in basal blood pressure in both genotypes (Avendaño et al., 2014). 
The observed phenotypes in Drosophila and Mus musculus are reminiscent of those observed 
for the attenuation of the inhibitor of muscle differentiation gene him (Soler and Taylor, 2009) 
and of the reduction of p38MAPK activity both in Drosophila and in vertebrates (Perdiguero et 
al., 2007b; Vrailas-Mortimer et al., 2011) (discussed below). However, it cannot be ruled out 
that, as so happens with the Notch ligand delta 1 (Schuster-Gossler et al., 2007) (a known 
inhibitor of the differentiation of myoblasts to myocytes), GRK2 loss can provoke a premature 
and excessive differentiation that would eventually lead to a loss of muscle fibers.  
In cell lines overexpressing GRK2, the expression of early and late key myogenic markers, such 
as MyoD and myogenin, or Caveolin-3 and MHC respectively, was strongly reduced in GRK2-
overexpressing cells. Accordingly, GRK2-expressing myoblasts did not differentiate properly. 
This is consistent with the phenotype observed for mice deficient for these marker proteins that 
show severe defects during myogenesis (Sabourin et al., 1999; Galbiati et al., 2001). In K220R-
expressing cells, a kinase-deficient mutant of GRK2 able to recapitulate events dependent on 
GRK2 scaffolding properties, but not those dependent on its kinase activity, the expression of 
early myogenic markers was not blunted, but rather accelerated what was indicative of a 
premature differentiation. This early maturation process was apparently successful in giving rise 
to multinucleated myotubes since, at day 4, K220R cells were morphologically 
indistinguishable from control cells. However, K220R myotubes did not reach the same degree 
of maturity as control cells, as indicated by the expression pattern of Caveolin-3 or MHC.  
In the absence of apparent differences in cell death or cell cycle exit between control and 
GRK2-expressing cells, other important early events are also decompensated. The activation of 
key protein kinases such as Akt and p38MAPK is impaired in GRK2 myoblasts and accelerated 
in both K220R-expressing C2C12 cells and upon GRK2 silencing. This effect was observed in 
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the phosphorylation of the Ser473 of Akt, which has been described to correlate with Akt kinase 
activity along myoblast differentiation (Gonzalez et al., 2004). More importantly, p38MAPK 
activation was more prominent all along the differentiation process in K220R-expressing or 
GRK2-silenced myoblasts, and blunted when GRK2 was elevated.  
This event can have important consequences in the development of myogenesis (Gonzalez et al., 
2004). Treatment with p38MAPKα/β inhibitor SB203580 prevented the fusion of myoblasts 
into myotubes, and the induction of muscle-specific genes (Cuenda and Cohen, 1999; Li et al., 
2000; Wu et al., 2000). Myoblasts obtained from mice lacking p38MAPKα showed impaired 
myoblast differentiation and fusion, with reduced expression of myogenin and MHC and 
blunted myotube formation (Perdiguero et al., 2007b). So, the kinase activity of p38MAPK is 
essential along the differentiation process, but it also serves to ensure the timely activation of 
different subsets of differentiation factors that guarantee a successful terminal differentiation 
(Penn et al., 2004). For instance, inhibition of p38MAPK activity during late stages of C2C12 
cell differentiation resulted in increased expression of certain skeletal muscle genes (Suelves et 
al., 2004). In particular, p38MAPK phosphorylated in vitro and in vivo certain residues in Nt-
MRF4, leading to a repressive but selective effect during terminal differentiation. Therefore, 
activation of p38MAPK at early time points triggers premature differentiation, but when that 
activation is maintained (as so happens with K220R overexpression or GRK2 silencing), it 
activates a repressive role of MRF4 over late myogenic markers and impairs terminal 
differentiation (Suelves et al., 2004). This effect might explain why in K220R-overexpressing 
cells differentiation is detected earlier but does not reach the degree of maturation observed in 
control cells. These cells, even when they differentiate well into long multinuclear myotubes 
containing more fused nuclei than control cells (data not shown), conserve the biochemical 
characteristics of immature myocytes, since they express significantly larger amounts of early 
differentiation markers such as MyoD and myogenin relative to control cells even when 
terminal differentiation is reached.  
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Overall, our data suggest that the phenotypic changes on the kinetics and degree of the 
myogenic process detected when GRK2 levels vary depend mostly on its kinase activity and are 
related to an altered p38MAPK activation status. This is in full accordance with the described 
effect that GRK2 protein has on the process of adipocyte differentiation in 3T3-L1 
preadipocytes. GRK2-mediated phosphorylation of the p38MAPK docking domain at the 
Thr123 residue prevents its interaction with substrates and activators and impedes progress of 
the differentiation process in a kinase-dependent manner (Peregrin et al., 2006). GRK2 might 
regulate skeletal muscle differentiation through a similar mechanism, since a phospho-mimetic 
mutant of p38MAPK (T123D) is able to recapitulate the effects of GRK2 overexpression on the 
myogenic process and to prevent formation of membrane protrusions, a process that should 
precede the formation of fused myotubes. On the other hand, the blunted differentiation 
observed in GRK2-expressing clones can be rescued by the activation of the p38MAPK route 
upon MKK6-E expression, strongly supporting the notion that modulation of the p38MAPK 
pathway is key to the effects of GRK2 in muscle differentiation. The fact that K220R-
expressing cells do not reach full differentiation maturity could be ascribed to an untimely 
p38MAPK activation pattern as discussed above, although we cannot rule out the possibility 
that at later stages of the normal differentiation process GRK2 activity towards alternative 
targets would contribute to some aspects of the differentiation process.  
The very early event of nuclei fusion is also altered by GRK2 expression. Myoblast fusion is 
initiated by finger-like membrane protrusions that search and engage neighboring fusion-
competent myoblasts to initiate the fusion process. Thus, the formation of 
filopodia/lamelipodia-like structures represents one of the earliest detectable events in the 
myocyte fusion process. Such actin-labeled protrusions are almost absent in GRK2-
overexpressing cells while K220R cells are fully able to generate membrane protrusions as 
control cells do. At day zero, before differentiation is initiated, K220R cells appear at least as 
competent as control cells to fuse to neighboring myoblasts, while GRK2 cells would be less 
able to extend and fuse their membranes. At day four, even when control cells and K220R cells 
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had the same amount of membrane protrusions, K220R cells had wider myotubes indicating 
more fusion events per myotube had occurred earlier on along the process. These results 
indicate that K220R cells are more competent or efficient in terms of promoting successful 
fusion events. So, it could be inferred that K220R cells possess a small but very precocious 
advantage during the first stages of fusion what eventually translates into larger myotubes with 
more fused nuclei. These myotubes would be, however immature, since early differentiation 
markers are still upregulated (and therefore would be causing differentiation to prolong), and 
late markers do not reach the levels achieved in control cells. Thus, these larger and 
multinucleated myotubes would remain immature in nature and, therefore, more prone to 
deterioration and detachment. GRK2 downregulation would cause fiber retraction due to 
hypercontraction of immature or dysfunctional myotubes, or by mechanical loss upon fiber 
detachment when the first contractile movements take place, what would explain the fiber loss 
that we detect in flies soon after birth. This phenomenon would also explain the fiber 
hypertrophy detected in adult mice, since the remaining fibers would grow larger in size and 
competency in an effort to compensate for fiber loss. Finally, it would also explain the lack of 
differences in muscle mass detected in GRK2-deficient animals, since deteriorated immature 
fibers can be replaced by hypertrophied larger ones, thus compensating for muscle mass loss. 
Given the connection between GRK2 activity and p38 pathways described in this work, 
investigating the extracellular stimuli regulating muscle GRK2 expression/activity during 
myogenesis or in muscle pathologies constitutes a very interesting avenue for future research. 
These extracellular signals may act through GPCR such as muscarinic or adrenergic receptors, 
leading to subsequent release of activating Gβγ subunits. A variety of GPCR and growth factors 
can also promote activation of kinases known to modulate GRK2 levels and/or activity, such as 
PKC, c-Src or MAPK (Ribas et al., 2007; Penela et al., 2010). β-adrenoceptors (βARs) play an 
important role in myogenesis and skeletal muscle regeneration after myotoxic injury cells 
(reviewed in Lynch and Ryall, 2008), and are also upregulated during differentiation of C2C12. 
On the other hand, the IGF1 pathway, which plays an important role in muscle growth, 
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maintenance and repair, has been shown to upregulate GRK2 expression in other cell types 
(Penela et al., 2010). Interestingly, GRK2 levels increase in muscle during aging and upon 
development of insulin resistance (Garcia-Guerra et al., 2010). Whether this increase contributes 
to age-related muscle wasting is however not known, Interestingly, βAR agonists have 
therapeutic potential for attenuating muscle wasting associated with age-, cancer cachexia, and 
neuromuscular diseases such as the muscular dystrophies (reviewed in Koopman et al., 2009). 
Also, a very recent report demonstrates that the loss in self-renewal detected in satellite cells 
from aged mice can be overcome by p38α/β inhibition (Bernet and Rudnicki, 2014). Whether 
GRK2 is found mutated or dysregulated in muscle wasting contexts or in human patients of 
muscular diseases are interesting questions for future studies. 
In sum, we can conclude that GRK2 provides important signals required to prevent uncontrolled 
early differentiation and to ensure sustained muscle differentiation during development. 
Modulation of GRK2 activity is of essential importance for skeletal muscle formation during 
development, and also determines fiber size and characteristics in adult mammalian tissue, 
probably by regulating the timely differentiation program and the development of fusion events 
at very early time points during the myogenic process. 
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Materials and methods   
Drosophila stocks 
The following stocks were used: Dmef2Gal4>UAS-GPF, 1151Gal4 (Dutta et al., 2004), 
UH3Gal4 (from Upendra Nongthomba, IISc, Bangalore, India) kettin-GFP (Kelso et al., 2004), 
Df(3R)Gprk2 and UAS-Gprk2i (Molnar et al., 2007), UAS-Gprk2, (a gift from C. Molnar and 
J.F. de Celis, CBMSO, Madrid). 
 
Cell line generation 
Mouse C2C12 myoblasts (American Type Culture Collection) (Blau et al., 1985) were 
maintained in DMEM supplemented with 10% fetal serum (FS) and antibiotics, at 37ºC and 5% 
CO2. C2C12 cells were stably transfected according to the LipofectAMINETM protocol 
(Invitrogen), with 4 µg of pcDNA3-GRK2-WT-neo (pc-GRK2) or pcDNA3-GRK2-K220R-
hygro (pc-K220R) or with the empty vector pcDNA3-hygro (pcDNA3) as a control. 
Afterwards, transfected cell lines were selected by neomycin (0.5 mg/ml) or hygromicin (0.5 
mg/ml) for 3 weeks. Four clones were obtained from each construct using this procedure, which 
were analyzed for GRK2 overexpression and differentiation pattern. Cells showed stable GRK2 
expression after several passages and no significant phenotypical differences among the four 
clones were observed in any group of cell lines. Accordingly, a representative clone from each 
group, pcDNA3, pc-GRK2 and pc-K220R, was used in this study. All cell lines were grown to 
confluence in 10% FS-DMEM before differentiation in low serum medium, DMEM 
supplemented with 2% horse serum (HS) for up to 4 days. Furthermore, C2C12 myoblasts were 
also subjected to transient transfection Flag-p38αWT or Flag-p38αT123D.These cells were also 
differentiated in 2% HS-DMEM for 4 days.  
 
Animal protocols 
Experiments were performed on Wt and hemizygous-GRK2 (GRK2+/-) mice maintained on the 
hybrid 129/SvJ C57BL/6 background. The animals were bred and housed on a 12-hour 
light/dark cycle with free access to food and water. Muscle samples were collected at the 
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corresponding ages and immediately weighted and frozen in liquid nitrogen and stored at -80°C. 
All animal experimentation described in this study was conducted in accordance with accepted 
standards of human animal care and approved by the University Committee. 
 
Please, refer to Supplementary Material for further information on this section. 
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Figure legends 
Figure 1 Gprk2 is required for Drosophila myogenesis. (A-C) lateral views of a stage 16 
Dmef2Gal4>UAS-GPF control embryo (A) showing the normal pattern of lateral and ventral 
somatic muscles (schematically represented in D), and the same Dmef2Gal4>UAS-GPF embryo 
visualized at 20h (B) and 24h (C) after injection of Gprk2 dsRNA. Note the aberrant 
morphology of the LT muscles in the anterior region of injected embryo (corresponding to the 
site of injection, arrow in B) and their detachment 4 h later (arrow in C) and compare to LT 
muscles in the posterior region of the embryos (arrowheads in A-C and arrow in the scheme 
shown in D). (E) Flightless phenotypes obtained after manipulation of Gprk2 expression using 
the UAS/Gal4 system at 29ºC. UAS-Ri-Gprk2, RNAi silencing construct for Gprk2. (F-I) 
Transverse sections of pupal (F, G) and adult thoraces (H, I). (F, H) w/+; UAS-Flp/+; FRT82 
Df(3R)Gprk2 / FRT82 M control thoraces, showing the wild-type arrangement of the six pairs of 
DLM muscles. (G, I) 1151Gal4/+; UAS-Flp/+; FRT82 Df(3R)Gprk2 / FRT82 M P8 pupa (G) 
and three days old fly (I) displaying a reduction in the number of DLM muscles (45%, n=11 in 
pupae, 47%, n=15 in 3 days old adults; arrow in panel G points at the left hemithorax containing 
5 DLM muscles).  
Figure 2 GRK2 hemizygous mice show decreased fiber number and increased skeletal muscle 
fiber size. Determination of GRK2 protein and gene expression in Wt and GRK2+/- mice by 
immunoblotting (A) and qPCR (B). Wt and GRK2+/- muscles were isolated and weighted (C), 
embedded in paraffin, cut in sections (5 µM) and stained with hematoxylin and eosin (D). 
Representative images are shown in 20× magnification. Scale bar 100 µm. The cross-sectional 
area of myofibers of the muscle from each individual mouse was measured to determine relative 
fiber size (Wt 3m=18.08±0.7 a.u.; Wt 9m=11.81±0.05 a.u.) (E) and the number of fibers (Wt 
3m=48.33±4.86; Wt 9m=50.91±2.36) (F) per field. Values are expressed as percentage over 
wildtype animals. Muscle sections from neonates were stained with MHC (G), and relative fiber 
size (Wt=3.01±0.08 a.u.) (H) and number of fibers (Wt=187.8±9.0) (I) per field were 
determined. Scale bar: 50 µm (20×) and 20 µm (60×). Values are expressed as percentage over 
wildtype animals. * P<0.01. 
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Figure 3 GRK2 impairs and GRK2-K220R accelerates myoblast differentiation. (A) C2C12 
myoblast were differentiated and lysed in successive days along the culture to analyze proteins 
by SDS-PAGE. Cell lines with increased expression of wild type GRK2 (pc-GRK2), 
catalytically inactive GRK2 (pc-K22R) or empty vector (pcDNA3) were used. (B) GRK2 
protein expression was immunodetected by western blot in control cells. (C) Phase-contrast 
images were taken along the differentiation process. (D) Representative western blot results 
using antibodies against MyoD, Myogenin, Caveolin-3, MHC and β-actin, and densitometric 
analysis after standarization using β-actin content. Both are results from 3 independent 
experiments. Values are expressed as percentage over zero days of differentiation. Different 
symbols show P<0.05; Asterisks depict differences between pcDNA3 and K220R, triangles 
between pcDNA3 and GRK2. 
Figure 4 Overexpression of GRK2 abrogates myoblasts fusion and membrane protrusions in 
low serum. Myoblasts from the cell lines pcDNA3, pc-GRK2 and pc-K220R were grown in 
10% FS-DMEM until confluence and then further cultured in 2% HS-DMEM for four days to 
induce differentiation. (A) Cells were fixed and actin cytoskeleton was visualized by 
fluorescence microscopy of cells stained with rhodamine-phalloidin. Nuclei were stained with 
DAPI. (B) Quantification of phalloidin–stained cells was conducted by scoring individual cells 
from 10 different fields for the presence or absence of membrane ruffles. Membrane protrusions 
are indicated by white arrows. The percentage of cells with fused nuclei (C), the number of 
nuclei per myotube (D) and the diameter of myotubes (a.u.) (E) were determined. * P<0.05. 
Figure 5 GRK2 kinase activity regulates the Akt, p38MAPK, and ERK1/2 pathways during 
myogenic differentiation. Cells were lysed at different days of culture and total protein (30 µg) 
was subjected to SDS-PAGE and immunodetected with total and phosphorylated forms of  Akt, 
ERK 1/2 (A) and  p38MAPK antibodies (B). Graphs in A and B show the densitometric 
analysis of P-Akt (Ser473), P-p38MAPK (Thr180/Tyr182) and P-ERK1/2 after standarization 
using total Akt, p38MAPK and ERK1/2, respectively. Values are expressed as percentage over 
zero days of differentiation. Results show representative blots of four independent experiments. 
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Asterisks represent differences between pcDNA3 and K220R, triangles between pcDNA3 and 
GRK2. * P<0.01. (C) C2C12 cells were infected with either a control adenovirus carrying GFP 
(Ad-CTRL) or an sh-GRK2 adenovirus (Ad-sh-GRK2), differentiated and lysed at different 
days along the differentiation process. Representative western blot results using antibodies 
against phosphorylated and total p38MAPK (Thr180/Tyr182) and AKT (Ser473) are shown. 
Graphs show densitometric analysis after standarization. *P<0.05, n=3. 
 Figure 6 Effects of a p38MAPK mutant that mimics its phosphorylation by GRK2 and of 
constitutive p38MAPK activation on a GRK2-overexpressing background. (A) Phase-contrast 
images of the terminally differentiated cells for detection of multinucleated myotubes. 
Magnification, 10×. (B) C2C12 cells transfected with Flag-p38αWT or Flag-p38α T123D were 
differentiated, fixed and immunostained with rhodamine-phalloidin (red) and DAPI to visualize 
actin cytoskeleton or nuclei, respectively. The percentage of membrane protrusions (C), 
percentage of cells with fused nuclei (D), number of nuclei per myotube (E), and myotube 
diameter (F) were determined. Four independent experiments were performed in triplicates. The 
images shown are representative from at least 10 different fields from independent coverslips. * 
P<0.05. (G) Both C2C12 and pcGRK2 stable cell lines were infected with a retrovirus carrying 
a constitutively active MKK6 mutant (MKK6-E) using an empty vector as a control. Cells were 
differentiated to take phase-contrast images and then lysed at the cero and the fourth day of the 
process. (H) Lysates were subjected to SDS-PAGE and immunodetected with antibodies against 
MHC, GRK2 and actin. 
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SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL DESIGN AND METHODS 
Reagents 
LipofectamineTM, culture media and sera were from Invitrogen (Paisley, UK). Neomicin and 
Hygromicin were purchased from Invitrogen (Carlsbad, CA). Antibodies were used against 
MyoD (sc-760), p38MAPKα (sc-535), myogenin (sc-576), MHC and GRK2 (sc-562) from 
Santa Cruz (Palo Alto, CA); β-actin from Sigma-Aldrich (St. Louis, MO); caveolin-3 from 
Transduction Laboratories (Lexington, KY); total and phosphorylated Akt (Ser473 and Thr308), 
p38MAPK (Thr180/Tyr182) and ERK1/2(Thr202/Tyr204) from Cell Signalling (Beverly, MA). 
The polyclonal anti-phospho-Thr123p38 serum was generated as described (Peregrin et al., 
2006). Autoradiography films were supplied by GE Healthcare (Rainham, UK). The plasmids 
pcDNA3-hygro, pcDNA3-GRK2-WT-neo, pcDNA3-GRK2-K220R-hygro, Flag-p38αWT or 
Flag-p38αT123D were previously used in our laboratory (Penela et al., 2008; Peregrin et al., 
2006). All other reagents used were of the purest grade available.   
 
dsRNA injection into embryos 
dsRNA was synthesized using the MEGAscript kit (Ambion) as in (Kennerdell and Carthew, 
1998) with modifications. 1h-old Dmef2Gal4>UAS-GPF embryos were injected with 2-3µM of 
gprk2-dsRNA in the ventral region at a central position using standard procedures, Voltalef oil 
covered embryos were let to develop at 17ºC in a humidified chamber and were observed at 
different times using a fluorescence microscope. 
 
Generation of Drosophila gprk2 mutant adult muscles and thorax sections 
To obtain adult muscles mutant for Gprk2 w; UAS-Flp; FRT82Df(3R)FRT82/TM6B females 
were crossed to 1151Gal4; FRT82M/TM2 males at 25ºC. Females 1151Gal4/+; UAS-Flp/+; 
FRT82 Df(3R)Gprk2 / FRT82 M were used to score for LOF phenotypes whereas their w/Y; 3 
UAS-Flp/+; FRT82 Df(3R)Gprk2 / FRT82 M siblings served as experimental controls. Pupae 
 2 
(P8) and adult thoraces were fixed with 4% paraformaldehyde (PFA) overnight, washed twice 
in water, dehydrated in acetone series and embedded in Epon. Sections (10 µm) were cut using a 
microtome and stained with Toluidine Blue. 
 
Analysis of cortical actin protrusions and fused nuclei. 
Overnight serum-starved cells plated in 35-mm tissue culture dishes and cultured as described 
above were fixed with 3.7% formaldehyde in PBS (pH 7.4) for 10 min at room temperature, 
washed in PBS, permeabilized in 0.2% Triton X-100 for 5 min, washed in PBS and incubated 
for 45 min with rhodamine-phalloidin (0.125 mg/ml) and DAPI to visualize cortical 
polymerized actin in protrusions of the cell membrane or the cells with fused nuclei respectively 
(Conejo and Lorenzo, 2001). Quantification of cells with actin-filled membrane protrusions was 
conducted by scoring individual cells from ten different fields for the presence of phalloidin-
stained membrane protrusions. The percentage of cells with fused nuclei was determined by 
dividing the number of DAPI-stained nuclei within myotubes (two or more nuclei) by the total 
number of nuclei analyzed. Number of nuclei in cells was counted and expressed as a 
percentage of the total number of nuclei analyzed. Myotube diameter was determined as the 
average from three measurements per myotube.  
 
Western blot. 
Cellular proteins (30 µg) were subjected to SDS-PAGE, transferred to Immobilon membranes 
and blocked using 5% nonfat dried milk in 10 mM Tris-HCl and 150 mM NaCl (pH 7.5), and 
incubated overnight with several antibodies as indicated in each case in 0.05% Tween-20, 1% 
non-fat dried milk in the same buffer. Immunoreactive bands were visualized using the 
enhanced chemiluminescence (ECL-Plus) Western blot protocol from GE Healthcare. In 
experiments using X-ray films, different exposure times were used to ensure that bands were not 
saturated. 
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Real-time quantitative RT-PCR (QPCR) assays. 
Total RNA was extracted from the gastronemius muscle of 3-month old GRK2+/- and wildtype 
mice (n=12, 6 mice per group) with Trizol reagent (Invitrogen). 1 µg of DNAseI-treated RNA 
was converted to first-strand cDNA with “High Capacity cDNA reverse transcription kit” 
(Applied Biosystems). The cDNA was subjected to real-time PCR assay for grk2 gene 
expression using the Taqman Gene Expression Assays from Applied Biosystems. Data obtained 
was analysed using the comparative method and by normalization of expression values of 18S 
rRNA expression. The results are expressed as fold increased over grk2 expression in wildtype 
animals.  
 
Analysis of myofiber size, total number of fibers and MHC staining. 
Samples were fixed in 4% paraformaldehyde and embedded in paraffin for histological analysis. 
Transverse paraffinized muscle sections (5 µm) were mounted on D-polylisinated glass slides 
and stained with hematoxylin and eosin. MHC staining was performed in freshly isolated 
muscles from 2-day old newborn mice fixed in 4% formalin and embedded in paraffin. 
Transverse sections (7 µm) were deparaffinized and rehydrated, and 3% H2O2 was used for 
blocking endogenous peroxidase activity. Sections were incubated with MHC antibody 
(Millipore). Immunohistochemical detection of MHC was performed following the staining 
procedure according to the vectastatin Elite ABC system (Vector laboratories) and 
counterstaining with hematoxylin. For each experimental group, five sections per animal were 
stained and a negative control without the primary antibody was performed. Digital images of 
skeletal muscle sections were captured using a light microscope (Olympus, Germany) at 20 and 
60X magnification. Relative fiber size and number of fibers were calculated in arbitrary fields; 
by quantitation of 50-100 adjacent muscle fibers in at least three different randomly-chosen 
fields per mouse, using image analysis software (ImageJ).  
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Propidium iodide incorporation assay. 
C2C12 myoblasts, pc-GRK2 and pc-K220R cell lines were cultured and differentiated as 
previously mentioned. Fresh differentiation medium was added every two days. At day four 
cells were washed twice with phosphate-buffered saline (PBS) and resuspended in Staining 
Buffer (PBS 1X, 1% BSA, 0.01% NaN3, 1% FBS) with a final concentration of propidium 
iodide (PI) of 1µg/ml. Analysis was carried out in a BD FacsCalibur flow cytometer (BD-
Bioscience) and propidium iodide-positive cells were quantified using CellQuest Software (BD-
Bioscience) and analyzed with the FlowJo Software.  
 
Adenoviral  infection. 
Cells were cultured in 10% FS-DMEM without antibiotics 24 hours before infection, then 
infected at a 150 M.O.I. with a rat adenovirus carrying an sh-GRK2 construct (Lafarga et al., 
2012) using a GFP-containing adenovirus as a control. After 8 hours of infection, the medium 
was replaced with 2% HS-DMEM up to 4 days.  
 
Retroviral  infection. 
293T cells were transiently transfected using standard LipofectAMINETM protocol with 5 µg 
of the packaging construct pCL-Eco and 5 µg of pMSCVp38α or pCLNCX MKK6E plasmids 
(kindly provided by Drs. Eusebio Perdiguero and Pura Muñoz; Perdiguero et al., 2011). The 
next day the medium was replaced with fresh medium. After 24 hours, the virus-containing 
medium was collected and centrifuged.100 µl of HEPES buffer solution (GIBCO, 1M) and 40 
µl of polybren solution (1 mg/ml) were added to the virus-containing supernatant, which was 
then added to C2C12 myoblasts and pc-GRK2 cell line. After 12 hours of infection, the medium 
was replaced with 2% HS-DMEM. 
 
Data analysis 
Results are means ± S.E. from 4 to 10 independent experiments. Statistical significance was 
tested with the unpaired Student’s t test or with the one-way ANOVA followed by the protected 
 5 
least-significant different test. Differences were considered statistically significant when P 
values were <0.05.  
 
LEGENDS TO SUPPLEMENTAL MATERIAL 
Supplemental Movie 1. Climbing assay in 3 day-old control flies. Climbing control assay in 
three days old w/+; UAS-Flp/+; FRT82 Df(3R)Gprk2 / FRT82 M flies. 
 
Supplemental Movie 2. Climbing assay in 3 day-old Gprk2 mutant flies. Climbing assay of 
three days old 1151Gal4/+; UAS-Flp/+; FRT82 Df(3R)Gprk2 / FRT82 M flies showing that in 
the absence of the Gprk2 adult muscle function the adults present a reduction in climbing speed 
compared with the control.  
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Supplemental Figure S1:  GRK2+/- mice display no differences in food or water intake compared to 
control littermates. Water (A) and food (B) intake were measured periodically in LabMaster 
metabolic cages, from TSE Systems (Bad Homburg, Germany) along 72 hours. Before the measure, 
mice were allowed to adapt to the new environment for 72 h. Measurements were taken every 10 min 
during 24 h. Results are expressed as ml of water or g of chow respectively, per mouse and day. Data 
were analysed with Phenomaster software (TSE Systems) and are means ± SEM of measurements 
obtained for from 5 animals per group. 
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Supplemental Figure S2: Different clones were generated among transfected C2C12 myoblasts and different
clones overexpressing either wild type GRK2 (pc-GRK2) or a catalytically inactive GRK2 mutant (pc-K220R)
were selected (A) Phase contrast images were taken during the differentiation process (B) GRK2 levels in
Actin Actin
. - .
undifferentiated C2C12, pc-GRK2 and pc-K220R myoblast lysates were immunodetected by Western Blot. The
fold overexpression was quantified by densitometric analysis and shown bellow the blots. (C) Representative
Western blot results using antibodies against Myogenin and Actin.
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Supplemental Figure S3: C2C12, pc-GRK2 and pc-K220R cell lines were differentiated and 
cell viability was determined at day four using a propidium iodide incorporation assay by FACS 
analysis. The percentage of propidium iodide-positive cells was calculated as a measure of cell 
death in each population. Data are mean±SEM of three independent experiments.
Supplemental Figure S4
0
50
100
150
%
G
o
/G
1
c
e
ll
s
B
      Days 0 4 0 4 0 4
* * *
p
c
D
N
A
3
p
c
-G
R
K
2
p
c
-K
2
2
0
R
A
p21
ppRB
pRB
PCNA
      Days 40 1 2 3 40 1 2 3 40 1 2 3
      pcDNA3       pc-GRK2       pc-K220R
Rb
b-actin
0
20
40
60
R
b
h
y
p
e
r
/h
y
p
o
p
h
o
s
p
h
o
r
y
la
te
d
(%
o
v
e
r
0
d
a
y
s
)
0
100
200
300
400
P
C
N
A
(%
o
v
e
r
0
d
a
y
s
)
      Days 0 4 0 4 0 4
p
c
D
N
A
3
p
c
-G
R
K
2
p
c
-K
2
2
0
R
      Days 0 4 0 4 0 4
p
c
D
N
A
3
p
c
-G
R
K
2
p
c
-K
2
2
0
R
0
200
400
600
p
2
1
(%
o
v
e
r
0
d
a
y
s
)
      Days 0 4 0 4 0 4
p
c
D
N
A
3
p
c
-G
R
K
2
p
c
-K
2
2
0
R
*
*
*
* *
* * * *
Supplemental Figure S4: Overexpression of GRK2 or GRK2-K220R does not alter cell cycle exit. C2C12 myoblast 
were differentiated and lysed in successive days along the culture to analyze proteins by SDS-PAGE. Cell lines with 
increased expression of GRK2 (pc-GRK2), catalytically inactive GRK2 (pc-K220R) or empty vector (pcDNA3) were 
used. (A) Representative Western blot results using antibodies against PCNA (Roche Molecular Biochemicals); Rb 
(Pharmingen); p21 (sc-397, Santa Cruz) and b-actin are shown. Graphs show densitometric analysis after 
standardization using b-actin content. Values are expressed as percentage over 0 days of differentiation. (B) Analysis 
of cellular DNA content was performed by flow cytometry. Cells were trypsinized, counted, washed with PBS, and 
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fixed with cold ethanol (70%). Then they were resuspended in PBS (10  cells/ml), treated with ribonuclease (Roche 
Diagnostics, Indianapolis, IN) for 30 min at 37ºC, and analyzed by flow cytometry. Results are expressed as 
percentage of cells in the phases G0/G1 of the cell cycle. * P<0.01
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Supplemental Figure S5: C2C12 cells were infected with either a control adenovirus carriying GFP (Ad-
CTRL) or an sh-GRK2 adenovirus (Ad-sh-GRK2) before differenciation. (A) Phase-contrast images were 
taken during the differentiation process. (B) The cells were lysed in successive days from day 0 to 4 and 30 μg 
of lysates were subjected to SDS-PAGE and immunodetected with an antibody against GRK2. Graphs show 
densitometric analysis after standarization. Data correspond to representative sets out of at least three 
independent experiments ** P<0.01.
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Supplemental Figure S6: (A) Myoblasts from the cell lines pcDNA3, pc-GRK2 and pc-K220R were grown in 
10% FS-DMEM and lysed. Lysates were immunodetected with antibodies against GRK2, P-p38MAPK 
(Thr180/Tyr182), P-p38MAPK (Thr123), total p38MAPK and b-actin. Graphs show densitometric analysis 
after standarization using p38MAPK. Values are expressed as arbitrary units (a.u.). Results show representative 
blots of four independent experiments. * P<0.01. (B) C2C12 cells transfected with Flag-p38aWT or Flag-p38a 
T123D were analyzed for Flag expression by immunoprecipitation and western blot using Anti-Flag antibodies. 
A densitometric quantitative analysis is shown. * P<0.05. (C) C2C12 and pc-GRK2 cells were infected with a 
retroviral construct carrying MKK6-E, differenciated and then lysed at days 0 and 4. Lysates were subjected to 
SDS-PAGE and immunodetected with antibodies against MHC,GRK2, P-p38MAPK (Thr180/Tyr182), 
p38MAPK and actin.  Graphs show densitometric analysis after standarization. Values are expressed as fold 
increase over cero days of differentiation. Data are mean±SEM of three independent experiments.
